AI Portfolio Summary
In 2025 Q4, BIOS Capital Management, LP maintained a portfolio of 6 distinct positions. The fund also reduced its exposure to IN8BIO INC by 11.6%.
Total Positions
6
Quarter
2025 Q4
Top Holding
ACTU (74.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-6 of 6
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ACTU
ACTUATE THERAPE...
|
Unknown | 74.44% | 75.62% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
10,049,996 | $61,505,976 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGTX
COGNITION THERA...
|
Unknown | 9.80% | 9.11% |
#2
Prev: #2
|
3.9 | no change | no change |
P
S
|
6,000,000 | $8,100,001 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRD
OPUS GENETICS I...
|
Unknown | 8.96% | 7.42% |
#3
Prev: #3
|
3.6 | no change | no change |
P
S
|
3,683,429 | $7,403,692 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LTRN
LANTERN PHARMA ...
|
Unknown | 3.70% | 4.97% |
#4
Prev: #4
|
1.5 | -6,208 | -0.6% |
P
S
|
1,009,507 | $3,058,806 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNTX
REIN THERAPEUTI...
|
Unknown | 2.37% | 2.19% |
#5
Prev: #5
|
0.9 | no change | no change |
P
S
|
1,690,751 | $1,961,271 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INAB
IN8BIO INC
|
Unknown | 0.72% | 0.70% |
#6
Prev: #6
|
0.3 | -33,247 | -11.6% |
P
S
|
253,417 | $592,996 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-6 of 6 holdings